publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
new
factor
influenc
pathogen
detect
molecular
assay
children
mild
sever
hand
foot
mouth
diseas
studi
aim
find
novel
inform
concern
pathogen
detect
probabl
coinfect
factor
hand
foot
mouth
diseas
hfmd
studi
clinic
diagnos
hfmd
patient
includ
enteroviru
coxsackieviru
differ
respiratori
pathogen
examin
nasopharyng
swab
use
polymeras
chain
reaction
pcr
revers
transcriptas
pcr
rtpcr
evalu
immun
activ
hfmd
patient
cytokin
igm
antibodi
mild
sever
patient
detect
result
indic
sever
hfmd
may
affect
pathogen
detect
lower
posit
rate
enteroviru
respiratori
virus
sever
hfmd
case
rtpcr
probabl
relat
stronger
immun
respons
therefor
immunolog
test
elisa
essenti
supplement
pcr
rtpcr
order
increas
pathogen
diagnosi
hfmd
especi
sever
case
hand
foot
mouth
diseas
hfmd
gener
febril
exanthemat
diseas
mostli
preval
children
younger
year
age
manifest
vesicl
palmar
plantar
surfac
hand
feet
buccal
mucosa
tongu
buttock
although
type
enteroviru
ev
coxsacki
viru
relat
hfmd
human
coxsackieviru
main
pathogen
bruu
sever
case
neurolog
cardiopulmonari
complic
asept
mening
enceph
poliomyelitislik
paralysi
mainli
caus
chong
et
al
mcminn
et
al
wang
et
al
weng
et
al
addit
associ
higher
mortal
rate
earli
diagnosi
hfmd
reli
typic
clinic
manifest
togeth
rtpcr
assay
nasopharyng
swab
vesicular
fluid
fece
detect
rate
variou
ev
rang
chen
et
al
jiang
et
al
singh
et
al
yang
et
al
report
differ
type
sampl
earli
multipl
sampl
may
affect
posit
rate
rtpcr
singh
et
al
immun
detect
igm
antibodi
use
serum
sampl
meaning
earli
diagnosi
establish
hong
et
al
xu
et
al
howev
perform
method
fulli
evalu
recent
studi
indic
antivir
proinflammatori
inflammatori
cytokin
increas
ev
infect
especi
sever
hfmd
case
associ
certain
advers
outcom
chung
et
al
khong
et
al
lin
et
al
strong
abnorm
activ
immun
system
sever
hfmd
case
may
affect
method
choic
concern
pathogen
detect
use
either
molecular
method
immun
detect
focu
igm
antibodi
hand
report
variou
virus
human
adenoviru
hadv
noroviru
rotaviru
relat
fatal
hfmd
case
cardosa
et
al
liu
et
al
broader
insight
common
communityacquir
pathogen
cap
respiratori
virus
rv
chlamydophila
pneumonia
cp
mycoplasma
pneumonia
mp
coinfect
necessari
understand
pathogenesi
better
manag
hfmd
laboratori
detect
respiratori
pathogen
use
molecular
diagnost
test
rtpcr
frequent
use
febril
children
respiratori
symptom
wherea
method
detect
rate
still
need
addit
evalu
especi
situat
coinfect
ev
diagnost
microbiolog
infecti
diseas
current
instruct
author
read
declar
compli
instruct
state
condit
author
acknowledg
parti
agre
submit
version
agre
inclus
materi
origin
neither
publish
elsewher
submit
public
simultan
accept
paper
publish
elsewher
correspond
author
studi
respiratori
pathogen
examin
use
nasopharyng
swab
individu
hfmd
use
commerci
avail
pcr
rtpcr
kit
addit
eight
proinflammatori
inflammatori
cytokin
igm
antibodi
releas
infect
detect
use
serum
sampl
select
mild
sever
hfmd
case
studi
yield
novel
inform
concern
pathogen
detect
hfmd
case
obtain
approv
ethic
committe
beij
youan
hospit
beij
china
consent
studi
particip
total
clinic
diagnos
hfmd
patient
includ
studi
particip
attend
beij
youan
hospit
june
octob
compris
sever
case
mild
case
mean
age
male
sever
case
mean
age
male
mild
case
mean
age
male
patient
given
clinic
diagnosi
hfmd
senior
physician
special
train
accord
hfmd
clinic
diagnosi
guidelin
publish
chines
ministri
health
accord
guidelin
mild
case
character
fever
herpet
stomat
rash
hand
feet
case
neurolog
sign
cardiopulmonari
complic
asept
mening
enceph
poliomyelitislik
paralysi
defin
sever
case
nasopharyng
swab
patient
collect
within
day
onset
ill
patient
sampl
specimen
immedi
place
viru
transport
media
tube
yocon
beij
china
temporarili
store
analysi
within
hour
use
nasopharyng
swab
case
randomli
select
mild
case
mild
group
sever
case
sever
group
chosen
cap
detect
simultan
serum
sampl
collect
patient
immunolog
assay
sampl
mild
case
sever
case
serum
sampl
collect
time
nasopharyng
swab
store
use
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
accord
protocol
provid
revers
transcript
carri
use
revert
aid
first
strand
cdna
synthesi
kit
fermenta
shenzhen
china
follow
procedur
outlin
manufactur
analyz
use
onestep
rtpcr
detect
kit
da
gene
co
ltd
guangzhou
china
hfmd
case
overal
hospit
case
neg
investig
ev
infect
use
human
evu
fluoresc
rtpcr
diagnost
kit
da
gene
co
ltd
guangzhou
china
rtpcr
amplif
carri
use
pcr
instrument
stratagen
la
jolla
ca
usa
accord
manufactur
instruct
swab
chosen
cap
detect
multiplex
rtpcr
perform
use
seeplex
ace
detect
kit
seegen
hangzhou
china
rv
detect
follow
manufactur
instruct
cdna
sampl
use
viru
test
cdna
sampl
test
set
primer
one
set
test
human
hadv
human
metapneumoviru
human
coronaviru
hcov
human
parainfluenza
viru
hpiv
type
anoth
set
test
influenza
type
b
viru
human
rhinoviru
hrv
ab
human
respiratori
syncyti
viru
hrsv
ba
influenza
type
viru
flu
rtpcr
product
analyz
use
agaros
gel
electrophoresi
stain
ethidium
bromid
rtpcr
product
specif
viru
design
migrat
uniqu
posit
gel
correspond
molecular
weight
marker
enabl
identif
specif
viru
swab
chosen
cap
detect
presenc
cp
mp
dna
examin
use
diagnost
kit
da
gene
co
ltd
guangzhou
china
accord
manufactur
instruct
eight
differ
granulocytemacrophag
coloni
stimul
factor
gmcsf
tumor
necrosi
factor
tnf
detect
serum
sampl
liquid
chip
method
use
bioplex
human
cytokin
examin
kit
biorad
hercul
ca
usa
follow
instruct
provid
detect
serum
use
igm
elisa
kit
igm
elisa
kit
wantai
beij
china
follow
instruct
provid
data
enter
databas
analyz
use
spss
softwar
version
spss
chicago
il
usa
chisquar
test
use
qualit
variabl
test
use
quantit
variabl
subordin
normal
distribut
homogen
varianc
mannwhitneywilcoxon
test
use
quantit
variabl
normal
distribut
show
homogen
varianc
express
cytokin
compar
method
p
b
consid
statist
signific
hfmd
case
test
posit
case
posit
case
posit
two
posit
specif
mild
case
posit
two
coinfect
sever
case
identifi
posit
posit
posit
rate
mild
case
much
higher
sever
case
p
infect
sever
case
much
higher
mild
case
p
fig
case
posit
infant
age
year
age
year
older
year
fig
children
younger
year
compris
major
studi
particip
posit
test
result
tabl
show
distribut
posit
respiratori
pathogen
hfmd
patient
total
eight
type
rv
mp
detect
posit
total
posit
case
found
case
coinfect
multipl
pathogen
posit
rate
cap
mild
group
much
higher
sever
group
fig
age
distribut
rvmp
hfmd
patient
figur
show
rv
mp
posit
rate
hfmd
patient
among
variou
age
group
appar
differ
rv
detect
rate
among
group
observ
howev
mp
posit
rate
patient
year
age
evid
higher
group
p
mp
detect
rare
occur
group
year
age
term
season
distribut
case
posit
infect
june
juli
august
septemb
octob
fig
peak
incid
appear
occur
june
august
addit
case
detect
posit
ev
sever
hfmd
case
among
hfmd
case
posit
variou
respiratori
pathogen
detect
sever
group
mild
group
detail
inform
provid
tabl
posit
rate
mild
group
much
higher
sever
group
p
specif
particip
posit
rv
includ
hrv
ab
flu
hadv
hrsva
four
individu
coinfect
multipl
virus
sixteen
sever
case
posit
rv
compar
case
mild
group
rvposit
rate
mild
group
much
higher
sever
group
p
signific
differ
rv
detect
among
age
group
howev
rate
rvposit
case
septemb
octob
much
higher
month
p
term
cp
mp
detect
case
posit
mp
sever
group
mild
group
case
test
posit
cp
either
group
mpposit
case
mainli
found
patient
year
age
mpposit
percentag
significantli
higher
age
group
p
although
statist
signific
small
peak
mp
infect
observ
august
age
profil
season
distribut
respiratori
pathogen
shown
fig
sever
case
subdivid
evposit
group
case
evneg
group
evposit
group
case
identifi
respiratori
pathogen
infect
compar
case
evneg
group
signific
differ
detect
respiratori
pathogen
two
group
p
detail
eight
rvposit
case
found
evposit
group
evneg
group
correspondingli
mpposit
case
identifi
evposit
group
compar
evneg
group
signific
differ
rv
p
mp
detect
p
two
group
tabl
sever
case
capneg
case
capposit
capneg
case
posit
capposit
case
posit
signific
differ
ev
detect
rate
two
group
statist
p
eight
differ
cytokin
detect
serum
sampl
cytokin
extent
repres
immun
activ
hfmd
p
valu
mild
sever
group
gmcsf
tnf
fig
except
presenc
cytokin
shown
significantli
higher
sever
group
mild
group
case
detect
posit
elisa
serum
sampl
result
differ
hfmd
case
discord
rtpcr
method
sever
case
posit
mild
case
posit
posit
rate
sever
case
much
higher
mild
case
p
cocircul
hfmd
patient
frequent
describ
li
et
al
numer
hfmd
outbreak
high
morbid
mortal
occur
rang
differ
countri
region
lee
et
al
wu
et
al
overwhelm
viru
replic
combin
induct
massiv
inflammatori
cytokin
propos
respons
pathogenesi
khong
et
al
coinfect
respiratori
pathogen
may
anoth
factor
contribut
diseas
progress
cardosa
et
al
rapid
identif
caus
agent
hfmd
togeth
pathogen
respons
coinfect
help
clinic
manag
focus
attent
possibl
complic
also
import
regard
predict
sever
outbreak
initi
appropri
public
health
intervent
nucleotidebas
rtpcr
method
develop
use
mani
clinic
laboratori
de
crom
et
al
guney
et
al
watkinsriedel
et
al
effect
accur
virolog
inflammatori
cytokin
express
mild
sever
hfmd
case
eight
differ
cytokin
detect
cytokin
much
higher
sever
group
mild
group
cytokin
extent
repres
strength
immun
respons
hfmd
result
suggest
immun
respons
sever
case
enhanc
diagnosi
depend
correct
sampl
time
use
appropri
clinic
specimen
well
transport
laboratori
optim
condit
requir
close
cooper
laboratori
expert
clinician
howev
factor
affect
detect
rtpcr
present
studi
detect
cap
pathogen
use
molecularbas
method
pharyng
swab
immun
assay
serum
sampl
taken
patient
hfmd
analyz
hfmd
swab
use
rtpcr
still
lead
caus
diseas
major
posit
case
infect
addit
sever
case
posit
ev
result
ev
infect
ignor
clinic
practic
among
sever
case
posit
proport
patient
identifi
posit
particularli
high
interest
find
studi
posit
rate
mild
case
much
higher
sever
case
earlier
report
examin
pharyng
stool
vesicular
liquid
sampl
patient
use
rtpcr
method
show
rate
mild
case
sever
case
result
togeth
suggest
ev
detect
might
associ
sever
hfmd
among
posit
case
younger
year
age
year
consist
earlier
report
liu
et
al
peak
infect
occur
june
august
trend
peak
summer
fall
also
found
report
baek
et
al
age
profil
season
distribut
could
factor
affect
infect
hfmd
case
test
posit
respiratori
pathogen
rv
identif
rate
much
higher
mild
group
sever
group
similar
find
result
confirm
cap
infect
cap
carrier
exist
hfmd
case
howev
suggest
cap
enhanc
sever
hfmd
gener
expect
wherea
sever
hfmd
influenc
detect
cap
especi
rv
studi
suggest
hadv
infect
reason
death
sever
hfmd
patient
cardosa
et
al
howev
statist
differ
hadv
detect
sever
mild
group
studi
p
case
die
enceph
sever
group
detect
hrv
b
rv
infect
preval
septemb
octob
month
trend
found
studi
kim
et
al
therefor
even
though
incid
hfmd
drop
low
level
autumn
winter
coinfect
patient
hfmd
rv
ignor
incid
mp
cp
signific
differ
found
mild
sever
group
suggest
sever
hfmd
affect
mp
cp
detect
howev
mp
detect
much
common
patient
age
less
year
compar
age
group
incid
mp
cp
lower
report
defilippi
et
al
kese
et
al
mc
et
al
may
due
fact
focu
children
acut
respiratori
infect
defilippi
et
al
patient
winter
spring
like
epidem
cp
mp
kese
et
al
mc
et
al
mc
et
al
furthermor
may
pharyng
swab
special
viru
preserv
decreas
mp
cp
detect
rate
compar
sputum
sampl
use
studi
singl
sampl
may
also
decreas
detect
rate
studi
report
children
younger
year
major
studi
rare
infect
mp
cp
almasri
et
al
kamata
et
al
regard
cap
detect
statist
differ
found
evposit
group
evneg
group
result
indic
presenc
affect
detect
cap
correspondingli
term
detect
appar
differ
found
capposit
group
capneg
group
suggest
cap
also
influenc
detect
identif
rate
rv
ev
mild
group
much
higher
sever
group
rtpcr
therefor
hypothesi
propos
differ
result
stronger
activ
acut
immun
reaction
sever
patient
earlier
studi
indic
increas
proinflammatori
inflammatori
cytokin
secret
detect
ev
respiratori
pathogen
infect
cello
et
al
chung
et
al
et
al
khong
et
al
lin
et
al
studi
suggest
enhanc
express
tnf
associ
lifethreaten
complic
sever
hfmd
case
lin
et
al
lin
et
al
wang
et
al
cytokin
includ
transform
growth
factor
gmcsf
report
specif
nonspecif
antivir
effect
ank
et
al
brook
et
al
hong
et
al
huang
et
al
recent
studi
indic
infect
increas
express
protein
high
level
found
plasma
sever
hfmd
patient
enceph
function
enhanc
viral
clearanc
increas
express
boost
infiltr
cell
shen
et
al
therefor
strong
immunoreact
play
import
role
pathogenesi
sever
hfmd
also
might
affect
choic
detect
method
studi
seven
cytokin
much
higher
sever
case
mild
case
find
support
hypothesi
also
indic
detect
level
cytokin
may
util
auxiliari
diagnost
method
evalu
diseas
progress
detect
rate
serum
igm
sever
case
much
higher
mild
case
could
evid
enhanc
immun
respons
sever
hfmd
case
situat
stronger
immun
activ
sever
hfmd
coupl
gener
specif
antibodi
elimin
specif
pathogen
therefor
detect
rate
ev
rv
rtpcr
decreas
differ
mp
cp
detect
sever
group
mild
group
suggest
elimin
mechan
cpmp
infect
differ
rv
ev
immun
respons
take
place
evrv
infect
ineffect
cpmp
wherea
viru
isol
still
golden
standard
hfmd
diagnosi
detect
activ
replic
virus
rel
rtpcr
relev
studi
indic
detect
rate
viru
cultur
even
lower
rtpcr
posit
case
singh
et
al
practic
rtpcr
method
use
worldwid
de
crom
et
al
watkinsriedel
et
al
howev
enhanc
immunoreact
sever
hfmd
may
elimin
ev
rv
quickli
nasopharynx
thu
decreas
detect
rate
rtpcr
altern
studi
indic
posit
rate
igm
antibodi
could
get
day
onset
xu
et
al
xu
et
al
rapid
gener
antibodi
confirm
present
studi
hand
clarifi
characterist
immun
respons
ev
view
rtpcr
detect
combin
serum
immunoassay
elisa
cytokin
profil
detect
could
use
earli
diagnosi
ev
infect
especi
case
sever
hfmd
conclus
result
illustr
sever
hfmd
influenc
pathogen
detect
hfmd
furthermor
lower
posit
rate
ev
rv
clinic
sever
case
possibl
due
stronger
immun
respons
therefor
immunolog
test
elisa
cytokin
detect
could
essenti
supplement
rtpcr
order
increas
pathogen
diagnosi
hfmd
patient
especi
sever
clinic
case
